Events Calendar

The events calendar is for in-person industry events. Please do not post online events to the event calendar.

» Submit an event

Jump to a month:

January 2017

6th Trial Master File Summit

January 17-19, 2017

Loews Royal Pacific Resort at Universal Orlando, Orlando, FL, United States

For six years now, ExL Events has brought together TMF professionals from all over the world to discuss and solve the latest issues in TMF management. Hundreds of people have attended events in our Trial Master File Series, which spans three continents, and have gone back to their organizations armed with the tools they needed to improve their overall processes. Come and hear unique case studies, panel discussions and training workshops from some of the leading TMF professionals in the industry. With the all-star cast that the 6th Trial Master File boasts, this will surely be an event you will not want to miss.

9th Social Media in the Pharmaceutical Industry

January 18-19, 2017

Holiday Inn Kensington Forum, London, Non-U.S., United Kingdom

Join us as SMi Group’s sell-out series Social Media in the Pharmaceutical Industry series returns in January 2017 for the ninth year. The two-day conference will bring together industry experts, regulatory bodies and leading pharma companies to discuss the latest trends like identifying influencers and monitoring data on a global scale. View the full agenda at and follow the conversation using #pharmasocialmedia on Twitter @smipharm. Communications is advancing and social media is the digital platform where global conversations are taking place. mHealth revenue is expected to reach USD 26 billion by 2017 and the number of health apps have increased exponentially, enabling consumer engagement and empowerment. Social media is not only being used to communicate, It is playing an important role in identifying trends, challenges and listening to what patients are talking about. Hear from key opinion leaders on how best to harness new technology and invaluable case studies, teaching you how to develop a robust digital strategy. With the series' biggest speaker line-up to date, this year's agenda will feature key opinion leaders and pharmaceutical companies at the cutting edge of social media innovation including MHRA, Creation Healthcare, MSD, Lundbeck, Pfizer, GE Healthcare, AbbVie, Janssen, Leo Pharma, Accenture, Digital Health and Care Alliance and more. In addition, two half-day pre-conference workshops on 17 January 2017: A: How will the rise of private messaging challenge the pharma industry? Hosted by Lundbeck B: Online influencer identification and mapping Hosted by the Conversationalist Agency Book by 30th September and save GBP 400. Book by 31st October and save GBP 200. Book by 30th November and save GBP 100. Keep up-date on Twitter @smipharm and conference hashtag #pharmasocialmedia

Pharmaceutical Microbiology

January 18-19, 2017

Holiday Inn Kensington Forum, London, Non-U.S., United Kingdom

SMi proudly presents the return of the 6th annual Pharmaceutical Microbiology conference to London in 2017! The microbiology market has significantly grown in recent years as the demand from end user industries increases. With this expansion and increased demand comes hurdles for the industry. SMi’s 6th annual Pharmaceutical Microbiology conference will address the complex challenge that the field is facing such as endotoxin testing, best practices in cleaning & disinfection and contamination control case studies. The comprehensive agenda will include presentations from both regulatory and industry experts sharing recent case studies and developing trends in the field of pharmaceutical microbiology. Expert speaker line-up includes: Sanofi Pharma, Bristol Myers Squibb, MHRA, Merial Sas, GSK, Shire Laboratories, Sanofi Pharma, and many more. For further information please get in touch with Matthew Apps on +44 (0) 207 827 6093 or or visit

GMP requirements for quality control and contract laboratories 2016

January 23-24, 2017

The Leela Mumbai Andheri Kurla Road, Sahar Village, Andheri-Kurla Road, Mumbai, Maharashtra 400059, Mumbai, CA, United States

Overview: Quality control and related contract laboratories are considered at high risk because after testing and approval, drug products and Active Pharmaceutical Ingredients (APIs) are released to the market without further check. That's the reason why the FDA and other agencies put highest emphasis on inspections of QC laboratories. Even though cGMP regulations have been in place since long time, the large number of QC related 483's and warning letters demonstrate that companies have problems with implementation. This two day interactive in-person seminar will provide participants the regulatory background and guidelines through all critical areas of GMP compliance. This course helps attendees understand the latest requirements and also provides them templates and examples to develop inspection ready documentation. Practical examples and interactive exercises will be dispersed into and between the presentations while 50% of the total time will be dedicated to practical sessions. During the seminar, participants will work in small groups on case studies and prepare the answers using prepared fill-in templates. After the course a large variety of tools such as SOPs, validation examples and checklists will be readily available on a dedicated website that can be used to easily implement what they have learned from the course. Learning Objectives: • Learn about the regulatory background and GMP requirements for quality control and contract laboratories. • Understand and be able to explain your company's quality plan or laboratory compliance master plan. • Understand the difference between GMP and non-GMP laboratories. • Learn how to develop inspection ready documentation. • Be able to train others in your organization on GMP requirements. • Learn how to avoid and/or respond to the FDA inspectional observations and warning letters. Complimentary Hand-outs: For easy implementation, attendees will receive free access to "Laboratory Compliance Package" as Web download. This package includes 46 SOPs, a compliance master plan, checklist and templates that help to implement GMP requirements in laboratories • 50-Page primer: FDA GMP Compliance in Analytical Laboratories • Laboratory Compliance Master Plan • Worksheet - Laboratory Audits • Following Standard Operating Procedures: Agenda: Day 1 Schedule: Lecture 1: FDA Regulations and Requirements Overview • FDA 21 CFR Part 211 and 21 CFR Part 11 • Most frequently cited FDA 483s and warning letters • Requirements overview from sampling to archiving • Quality system requirements, e.g., ICH Q10 • The concept and practice of risk based compliance Lecture 2: Planning for quality and cGMP compliance • Developing and using a validation master plan • Scope, objectives and key elements of the master plan • Developing and using FDA compliant SOPs • Using templates to generate inspection ready documentation • Planning for efficiency cost-effectiveness Lecture 3: Calibration and Qualification of Laboratory Equipment • FDA requirements • USP chapter for instrument qualification • Going through examples for qualification steps(DQ, IQ, OQ, PQ) • SOPs and deliverables for three instrument categories • Developing calibration and qualification protocols Lecture 4: Equipment Maintenance and Change control • Preventive maintenance; tasks, documentation • Planned and unplanned changes • Changing hardware, firmware, documentation • Definition and handling of like-for-like changes. • Requalification: time and event based Lecture 5: Validation of Laboratory Computer Systems • Going through the new GAMP® guide: "A Risk based Approach to Laboratory Computerized Systems" • Going through a complete laboratory computer system validation from beginning to end • Integration the GAMP® guide with USP • Periodic evaluation to reduce revalidation efforts • Revalidation: why, what, when Lecture 6: Validation of Analytical Methods and Procedures • Parameters and tests according to ICH Q2 • Developing a validation plan, protocols and a report • Setting acceptance criteria for different applications • Verification of compendia methods according to USP • Transfer of analytical procedures according to the new USP Day 2 Schedule: Lecture 1: Sample Testing: Preparation, conduct, documentation • Preparing the equipment • Setting specifications and acceptance criteria • Documentation of test results • Review and approval • Not to forget: Review of electronic audit trail Lecture 2: Handling out of specification (OOS) test results • Going through the FDA OOS guide • Learning from recent FDA warning letters • Going through an OOS checklist • Using out of trend (OOT) data to avoid OOS results • Documentation and follow-up: root cause, corrective action plan, preventive action plan Lecture 3: Quality assurance of reference standards and other supplies • Supplier qualification vs. sample testing • Selection and assessment of suppliers • Retesting of materials • Preparing working standards from reference standards • Correct labeling of chemicals Lecture 4: Training for GMP compliance • FDA requirements • identification of training needs • Developing a training plan • Making GMP training interesting • Documenting effectiveness of training Lecture 5: Ensuring Integrity of Raw Data and Other records • FDA Part 11 and EU-PIC/S Annex 11 requirements • Definition of Raw Data: Electronic vs. paper • Acquisition and recording of raw data • The importance of electronic audit trail • Archiving of electronic records for 'ready retrieval' Lecture 6: Internal audits in preparation for FDA inspection • Scheduling of audits • FDA Inspections as model for laboratory audits • Going through a typical FDA laboratory inspection • Responding to Typical inspectional/audit deviation • How to avoid FDA 483s and warning letters Lecture 7: Wrap up - Final questions and answers Speaker: Dr. Ludwig Huber Chief Advisor - Global FDA compliance, Agilent Technologies • Chairman, presenter and panel discussion member at US-FDA Industry Training sessions and conferences • Served as team member of PDA's task forces "21 CFR Part 11", of US-FDA internal documents, and of the GAMP® special interest group on Laboratory Systems. • Presenter of the Year of the Institute for Validation and Technology • Director and chief editor of, the global on-line resource for validation and compliance issues for laboratories. • Author of the books "Validation and Qualification in Analytical Laboratories, and "Validation of Computerized Analytical and Networked Systems" Location: Mumbai, India Date: January 23rd and 24th, 2017 and Time: 9:00 AM to 6:00 PM Venue: The Leela Mumbai Address: Andheri Kurla Road, Sahar Village, Andheri-Kurla Road, Mumbai, Maharashtra 400059 Price: Register now and save ₹ 2000. (Early Bird) Until December 10, Early Bird Price: ₹ 14,000 from December 11 to January 21, Regular Price: ₹ 16,000 Registration Details: NetZealous - GlobalCompliancePanel NetZealous Services India Pvt. Ltd. Gururaya Mansion, 759 to 764, 8th Main road, J.P.Nagar, Bangalore - 560078 Karnataka, INDIA Phone: 1800 425 9409 Fax: 080-25149544 Registration Link - Follow us on LinkedIn:

Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions

January 26-27, 2017

Venue to be announced shortly, Orlando, FL, United States

Raw material requirements in a cGMP environment are often overlooked as a company develops new products. Depending on the product being developed, e.g., tablets and capsules vs. biotechnology products, as few as fifteen to twenty or as many as sixty raw materials need to be sourced before the process can be moved from initiation through completion. This highly interactive two day seminar on raw material requirements in a cGMP environment will: Consider Health Canada, FDA, USP and EP requirements. Examine a variety of the issues surrounding raw materials to include what materials should be tested and to what extent during Phase 1, 2, 3 and commercial production. Cover testing requirements during each phase and what may be optional (regulatory risk) until the product moves to its next phase. Determine what options exist - even within a Phase 2 or Phase 3 testing framework. Discuss compendial vs. non-compendial testing and how to respond when no method is available.

Commercializing Continuous Processing in Pharma 2017

January 30 - February 1, 2017

Sheraton Boston Hotel, Boston, MA, United States

Commercializing Continuous Processing in Pharma 2017, is the only dedicated conference to explore the different tactics to introduce, implement and improve your existing approach. Over the last 2 years, the pharma and biotech industry has been busy investing in their manufacturing facilities to drive productivity and product quality, hoping to shorten product’s time to market. Continuous processing is the most promising candidate which will remove bottlenecks in your production.

Essentials Of USP Microbiology - Reading Between the Lines of the USP General and Information Microbiology Chapters: 2-Day In-Person Seminar

January 31 - February 1, 2017

Venue to be announced shortly, Orlando, FL, United States

Course Description: The objective of this two day "Essentials of USP Microbiology" seminar is to explore USP General and General Information Chapters to learn which are available and to confirm that those that you are using are being used correctly. USP documents that will be reviewed include USP and others. Various team exercises will be conducted to allow the participants to use these USP documents to solve "real life" problems. Plan to bring a cross-functional group of your personnel to attend this invaluable two day seminar. 

Back to the top

February 2017

Advanced Analytics for Clinical Data 2017

February 1-2, 2017

Sheraton Fisherman’s Wharf, San Francisco, CA, United States

Advanced Analytics for Clinical Data 2017 brings together the leading experts in clinical data science, clinical innovation and clinical data management from major pharmaceutical and biotechnology companies. This meeting focuses on how to effectively implement big data analytics and data-driven methodologies in your clinical research.

2017 Pharma Market Research Conference USA

February 1-2, 2017

Hilton Parsippany Hotel, Parsippany, NJ, United States

The Pharma Market Research Conference offers an in-depth look at the future of pharmaceutical market research presented by internationally renowned speakers in first-class sessions. We bring together the top thought leaders in pharmaceutical, biotechnology, medical device, and diagnostics to create an environment of new ideas, connections and perspectives. Your VIP access includes valuable face time with other key decision makers, learning about the most crucial issues facing today’s market research community, and taking advantage of a world-class line up of speakers and panelists offering their unique insights and expertise on the topics you care about most. The Pharma Market Research Conference is widely attended by a large variety of professionals from large, medium-sized, and emerging pharmaceutical, biotechnology, medical device, and diagnostics companies. Market Research/Marketing Research Global Marketing/Marketing Brand Management/Product Management Strategic Planning/Business Planning Business Research Qualitative Research/Quantitative Research New Products/Product Planning and Analysis Business Intelligence/Competitive Intelligence Customer Insights Knowledge/Information Management Industrial Research/Information Customer-Scientific-Medical Research/Information Emarketing/eBusiness/eDetailing Business Development/Marketing and Sales

Parallel Trade

February 6-7, 2017

Holiday Inn Kensington Forum, London, Non-U.S., United Kingdom

With Brexit and the new EU Falsified Medicine Directive, what does the future hold for parallel trade? This event will discuss short term versus long term concerns of pharma manufacturers, regulators, as well as parallel traders. They will engage in an interactive debate and discuss how to keep abreast of the current trends and how to overcome all challenges. Discussion topics include: •Parallel Trade 101 - Which factors determine the flow of pharmaceutical products in Europe? •The European Commission’s Falsified Medicines Directive – recent updates •Panel Debate – In the spotlight: Shortages •The Patient’s perspective •Parallel traders panel – challenges and opportunities •Beyond pharmaceutical products – parallel imports of medical devices •Panel Debate - In the spotlight: Technology & new trends •Regional and country focus - Scandinavia, Germany, the UK, Central and Eastern Europe, Turkey and Eurasia This is the only industry meeting with 80+ selected senior leaders in parallel trade to discuss upcoming trends and share best practices. Join us today to keep abreast and stay ahead of competition!

21st Annual ARC Industry Forum: Industry in Transition: Realizing the Digital Enterprise

February 6-9, 2017

Renaissance Orlando at SeaWorld, Orlando, FL, United States

How will disruptive technologies change existing products and plants? How will open source solutions impact traditional software and automation domains? Is digitalization a threat to cybersecurity and, if so, how can the risk be mitigated? How ‘smart’ are smart machines, and what benefit will these bring? How do Big Data and predictive and prescriptive analytics enable operational change? How do connected products create opportunities in aftermarket services? What software capabilities are needed to achieve transformational change? Which industries are already changing? What steps can organizations take to foster innovative thinking? Join us at the 21st annual ARC Industry Forum in Orlando, Florida to learn more about how the digital enterprise will be realized and the benefits that this can bring. Discover what your peers are doing today and what steps they are taking in their respective journeys.

World Affordable Medicines Congress

February 7-8, 2017

Catalonia Plaza Barcelona Hotel, Barcelona, Non-U.S., Spain

The event unites senior executives from the generic and biosimilar industry to provide fresh insights future market trends, innovative commercial strategies and opportunities for growth for affordable medicines. Through a mixture of plenary keynote sessions, roundtables, focused work streams, the event will address a comprehensive range of key topics, including: Making medicines affordable CEO Panel Building scale and market share Mature and emerging market review Payers perspective and pricing trends Biosimilar development challenges Pharmacovogilance and post launch safety monitoring Clinical development strategies Developments in global intellectual property Regulatory strategy for generics and biosimilars How is the health policy landscape supporting affordable medicines? How to develop an integrated approach to biosimilar development and commercialization

People in Life Sciences HR Summit

February 8-9, 2017

HILTON SAN DIEGO/DEL MAR, San Diego, CA, United States

People in Life Sciences Summit is a talent management conference designed to address the recruitment, development and retention issues unique to managing talent within the medical device, pharmaceuticals, and biotechnology industries.

2017 GPhA Annual Meeting

February 13-15, 2017

JW Marriott Orlando Grande Lakes, Orlando, FL, United States

Welcome to the GPhA 2017 Annual Meeting! Each year, nearly 700 attendees gather to gain insight on how the nation's most critical health and regulatory issues will impact the generic industry and the consumers who benefit from access to affordable medicines.

Our meeting attracts leading speakers from around the globe who will leave attendees with a comprehensive understanding of the opportunities and challenges for the generic pharmaceutical sector in 2017. This lineup – combined with unparalleled networking opportunities – makes GPhA's Annual Meeting the generic industry event of the year.

GPhA’s Annual Business Exposition offers a highly interactive and professional business environment in which industry vendors can meet generic industry executives. Building on the success of prior years, we offer our exhibitors abundant networking time with industry decision-makers by hosting breakfasts and breaks in the Expo ballroom as well as an Exhibit Hall Meet and Greet on Monday prior to the Welcome Reception. And the Tuesday afternoon GPhA Business Expo Reception has proven to be a highly profitable time for our exhibitors. Register Today!

Biologistics World Asia 2017

February 15-16, 2017

Singapore, Singapore, Non-U.S., Singapore

Biologistics World Asia will be the MOST Targeted event in Asia that focuses on cold- chain logistics for biomedical products. Bioplogistics World Asia 2017 will be attended by decision makers from regional and international biopharmaceuticals and biotechnology firms, top CMOs and CROs, government organizations and key global and Asian regulators. It’s your one stop solution to reach out to Asia’s logistics and supply chain industry!

Biologistics World Korea 2017

February 15-16, 2017

Seoul, Korea, Seoul, Non-U.S., Korea South

Biologistics World Korea is the MOST Targeted event in Korea that focuses on supply chain management and logistics for biologics and vaccines.The programme promises to bring together key opinion leaders, rising players and market experts to discuss, debate and brainstorm on the most pertinent issues affecting Korea’s logistics network within a global context!

Effective Design, Validation and Routine Maintenance of Pharmaceutical Water

February 16-17, 2017

Venue to be announced shortly, San Diego, CA, United States

This seminar will help the attendee gain an understanding of the requirements of Pharmaceutical Water Systems per current USP Water for Pharmaceutical Purposes. This seminar will describe the different types of pharmaceutical water systems, the importance of the design of a water system and applications as well as how the design relates to and affects the successful validation and future routine testing. This seminar will also guide a drug product manufacturer with a new or existing water system about the appropriate types of routine testing frequency, types of testing as well as how to set an acceptable alert and action levels for the different water systems. This seminar will also cover water test result/data management and trending in order to guide the user about the best way to have a steady state of control of the different water system. This will help the user or manufacturers to avoid future pharmaceutical water failure investigation or inability to validate or get a good test results from the new water system due to design related issues.

12th Annual Biomarkers Congress

February 21-22, 2017

Manchester Central Convention Complex, Manchester, Non-U.S., United Kingdom

Oxford Global is proud to present its 12th Annual Biomarkers Congress taking place on the 21-22 February 2017 in Manchester. Our renowned congress will bring together over 300 attendees, speakers and vendor companies from pharmaceutical and biotechnology companies as well as academia. In line with the current industry trends, the flagship event this year focuses on the discovery, development and clinical development of biomarkers in Autoimmune, Immuno-oncology, Neuroscience, Oncology as well as Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome. Our expert speakers will also cover innovations in Biomarker research such as imaging biomarkers and assay development, big data challenges in biomarker research, new advances in biomarker technologies and platforms; insights into the human proteome atlas, population genetics, systems biology and their implications in Biomarker development. Do not miss out on gaining insights on the role of biomarkers in clinical development, clinical trials and clinical diagnostics. Sponsored by over 50 international leading solution provider companies, the two-day congress highlights formal or informal discussions and pre-organised 1-2-1 meetings For the latest updates to the programme, our complimentary webinars, and attendance opportunities, please visit our website at

Cell Culture and Downstream World Congress 2017

February 21-22, 2017

Sofitel Munich Bayerpost, München, Non-U.S., Germany

In 2017 we are combining the Cell Culture World Congress and the Downstream Processing World Congress, to bring you the Cell Culture and Downstream World Congress 2017, an all-encompassing event covering the whole manufacture and bioprocess life cycle. We are also introducing our new Formulation, Fill and Finish stream, where we look to cover important issues such as formulating high concentration biologics, freeze-drying for stability and longevity, novel filling technologies and a lot more. Across the event we will be showcasing exciting new technologies such as CRISPR gene editing, 3D printing of bioreactors and new methods of vaccine production. Content will include cutting edge research and even more case studies, over 70 presentations from those working in manufacture, bioprocess and formulation, fill and finish in big pharma and interactive sessions with biotechs.

eyeforpharma Data and Technology in Clinical Trials 2017

February 21-22, 2017

Sonesta Hotel, Philadelphia, PA, United States

eyeforpharma’s Data and Technology in Clinical Trials 2017 is here to guide you through the maze. We understand how overwhelming predicting a digital strategy can be, with the potential being so huge and the need to uphold, above all, the safety of patients and quality of data. That’s why we’re bringing together the most innovative clinical minds to share their experiences and inspire the industry. Hear from the likes of Murray Stewart, GSK, David Christie, Amgen and Brooks Fowler, AbbVie, who are all piloting change within their organisations, as to where they first saw the opportunities, any challenges they have overcome, and the tangible, quantifiable outcomes they have enjoyed.

3D Cell Culture 2017

February 22-23, 2017

Copthorne Tara Hotel, London, Non-U.S., United Kingdom

Following the success of the sell-out Cell Based Assay series, SMi Group is delighted to launch its inaugural conference on 3D Cell Culture which takes place on the 22nd and 23rd of February 2017 in London. The event is designed to address current and emerging applications of 3D cell culture, providing a platform for industry experts and clinical specialists within drug discovery, toxicology, stem cells, disease modelling and emerging technologies, to discuss the challenges and future directions of this technique. With a focus on clinical successes and emerging technologies, the conference will showcase how 3D Cell Culture has revolutionised drug discovery and toxicity screening, as well as how it is emerging as an invaluable tool in stem cell research and regenerative medicine. The event will also highlight exciting opportunities and latest innovations, spheroid and organoid techniques, as well as key developments in 3D and 4D bio-printing, microfluidics, CRISPR and the ongoing debate of 2D vs 3D cell culture. EXPERT SPEAKERS INCLUDE: # Stefan Przyborski, Professor of Cell Technology, University of Durham # Louisse Bisset, Senior Biologicals Quality Assessor, MHRA # Oliver Chao, Head of Emerging Biomedical Sciences, Sanofi-Aventis # Rasdoslaw Polanski, Senior Research Scientist, AstraZeneca # Robert Vries, Managing Director, Hubrecht Organoid Technology Foundations # Olaf Galuba, Scientist, Novartis # Christopher Schofield, Investigator, GlaxoSmithKline and more! For more information and to register, visit

RNA Therapeutics 2017

February 22-23, 2017

Copthorne Tara Hotel, London, Non-U.S., United Kingdom

SMi's 8th annual RNA Therapeutics conference will feature a mix of case study-led presentations, panel debates and interactive workshops tailored for an audience of professionals and research scientists looking to develop and commercialise novel RNA therapeutics and delivery systems. This exciting programme for 2017 will showcase new developments through clinical and pre-clinical results in topics such as: messenger RNA-based therapeutics, anti-sense oligonucleotides and new sites for RNA silencing.

AcademiaPharma 2017 - Developing Pharma Partnerships Summit

February 22-23, 2017

Wellcome Genome Campus Conference Centre, Wellcome Genome Campus Hinxton, CB10 1RQ, Cambridge, Non-U.S., United Kingdom

Academic institutions have always been at the forefront of innovation. Big pharma is facing major patent cliffs and slashing internal R and D budgets, whilst academia is finding it tougher to gain funding for research projects. This means that it is more important than ever for the two groups to establish meaningful and mutually beneficial relationships. Academia Pharma: Development Partnerships successfully creates a unique environment for leading industry professionals to share novel case studies, develop future strategies and most importantly create mutual partnerships to support drug development. The event will bring together an international community of experts from academia, biopharma, healthcare and research institutions and councils to share best practice in collaborative research and development. Topics of discussion include: Start-up to IPO: capitalising on scientific discovery; Influence of I.T. and Big Data on the laboratory; Drug Discovery; Funding Science in an increasingly risk-averse market; Scientific and real-world benefits of collaboration; Penetrating new markets: traditional technology firms and healthcare. Sponsorship packages are available and interested parties should contact:

IFPAC®-2017 31st International Forum & Exhibition

February 27 - March 2, 2017

Bethesda North Marriott, North Bethesda, MD, United States

Advanced Manufacturing Science… Emerging Technologies to Modernize Pharmaceutical/Biopharmaceutical Development and Manufacturing IFPAC continues to set precedence as a forum for insightful discussions bringing you the latest trends and real-life applications in the field for the pharmaceutical, biotechnology, generic, food, and other related industries.

IFPAC creates a unique platform to network and discuss the latest trends and technologies with industry, academic, and regulatory leaders. Join your colleagues for the latest developments in RTRT, continuous manufacturing, process validation, risk management, lifecycle management, models & model maintenance, ICH Q12/established conditions, bio-manufacturing/bio-processing, international harmonization, emerging & innovative technologies, control strategies, various analytical techniques, and more.

You will not want to miss out on the high quality presentations and opportunities for networking. Exhibition opportunities are also available. Register Today!

Joint MHRA/DIA Excellence in Pharmacovigilance

February 27 - March 3, 2017

Holiday Inn London Kensington Forum, 97 Cromwell Road, SW7 4DN, London, Non-U.S., United Kingdom

This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements. This five-day training course also includes highlights and updates on the pharmacovigilance legislation and the latest news on the international harmonisation and standardisation activities in pharmacovigilance. What you will learn - Definitions and Methods in Pharmacovigilance - Regulatory Aspects in Pharmacovigilance and Practial Examples - Diagnosis of Adverse Drug Reactions - Signal Detection and Signal Management - Modern Technologies and Social Media - Risk Management

Back to the top

March 2017

Pittcon 2017

March 5-9, 2017

McCormick Place, Chicago, IL, United States

Pittcon 2017 will be held March 5-9, 2017, in Chicago, Illinois, at McCormick Place West. Pittcon offers a unique, once a year opportunity to get a hands-on look at product innovations from leading companies and to learn the latest techniques from world-renowned members of the scientific community. Find solutions to all your laboratory challenges.

eyeforpharma Barcelona 2017

March 14-16, 2017

CCIB, Barcelona, Non-U.S., Spain

15th Annual eyeforpharma Barcelona 2016 is Europe’s largest commercial pharma meeting of 1000+ industry leaders focused on commercial innovation, engagement strategy, patient centricity and stakeholder collaboration. 1000+ delegates, 80+ senior level speakers, 3 tracks: Speakers Include: Gregory Behar, CEO, Nestle Health Science Richard Francis, CEO, Sandoz David Ricks, President Lilly Bio Medicines, Lilly Why Barcelona? Collaborative setting: In 2017, our aim is to ensure your key stakeholders are present to advance partnerships with healthcare, technology, patients and patient associations An inspiring agenda: As you undergo a commercial evolution we will provide 3 targeted tracks, intimate workshops and stakeholder sessions to help direct your journey 1000+ in attendance: If you are looking for one commercial meeting to attend in 2017, Barcelona will be sure to give you the most senior networking opportunity possible For more information visit:

DCAT Week ‘17

March 20-23, 2017

New York City, NY, United States

DCAT Week is the premier business development event for companies engaged in and supporting pharmaceutical development and manufacturing. Its unique model brings together members for high-level strategic meetings with key decision makers, timely educational programs and important networking opportunities. It is organized by the Drug, Chemical & Associated Technologies Association (DCAT).


March 21-23, 2017

Javits Center, New York, NY, United States

At INTERPHEX, find all of the State-of-the-Art Solutions you need to Cost Effectively Develop and Manufacture Product. INTERPHEX is a premier pharmaceutical, biotechnology, and medical device development and manufacturing event and sponsored by Parenteral Drug Association (PDA). Dedicated to Innovation, Technologies and Knowledge, the show focuses on the entire product development life cycle. Held in New York City, it brings over 10,000 global industry professionals together with 600+ suppliers through a unique combination of our no cost technical conference, exhibits, demonstrations, workshops, partnering opportunities, and networking events. . INTERPHEX offers annual national and international industry events and educational opportunities around the world. Follow INTERPHEX on Facebook, LinkedIn, Instagram, YouTube, and Twitter. IPX Blog continues the learning beyond the show floor. For more information, visit

Drug Discovery 2017

March 27-28, 2017

Holiday Inn Kensington Forum, London, Non-U.S., United Kingdom

SMi proudly presents its exclusive conference on Drug Discovery, taking place on 27th and 28th March 2017. In recent years, the Pharma/Biotech industry has undergone radical changes which have increased are understanding of drug discovery and development, however there are still many hurdles that the industry face. The gap between a laboratory discovery and an approved drug on the market is a decade-long process of laboratory testing, evaluation in animal models and human clinical trials that can cost hundreds of millions. The conference aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges. The conference will bring together industry leaders who will highlight future opportunities for novel therapeutic discovery. Some of our featured speakers include Lorenz Mayr, VP and Global Head, AstraZeneca Guido Hanaeur, Scientific Director Translational Medicine, Takeda Ulrich Schopfer, Executive Director, Head Integrated Lead Discovery, Novartis Yolanda Chong, Principal Scientist, Johnson and Johnson Matthias Frech, Director, Molecular Interactions and Biophysics, Merck Serono Wengard Czechtizky, Head of Chemistry, Sanofi Ulrich Schopfer, Executive Director, head Integrated Lead Discovery, Novartis Stephen Pickett, Senior Scientific Investigator, GSK Plus more from AbbVie, UCB Pharma, Eli Lilly, TissUse, Heptares and more. For more information and to register, kindly visit Early Bird rates: Book by 30 November to save GBP 400 Book by 16 December to save GBP 200 Book by 31 January to save GBP 100

29th Annual DIA EuroMeeting 2017

March 29-31, 2017

Scottish Exhibition & Conference Centre - SECC, Glasgow, Non-U.S., United Kingdom

The DIA EuroMeeting allows you to debate the issues across the entire drug development value chain during the conference & find solutions within the exhibition with 2,500+ other cross functional thought leaders. You will hear the latest solutions and challenges in healthcare. You will have plenty of opportunities to network and build relationships with trend setters in e.g. the areas of regulatory science, clinical research and operations, value demonstration leads and patient advocates. The resulting knowledge transfer and lasting partnerships will reduce the burden of regulatory barriers, benefiting your business now and further down the line. Themes such as Innovation, Globalisation and Value & Access will utilise input from top speakers from different faculties to achieve solutions that can be applied in your own real-life settings. Other themes will close with roundtable discussions with the speakers and a summary given by the theme leader. We trust that this additional new format will further strengthen the ability to develop new insights and opinions at our conferences - for your benefit. Theme 1 Globalisation - What are the current successes and challenges? Theme 2 Innovation - What are the key success factors? Theme 3 Current Challenges in Clinical Research Theme 4 eHealth/Big Data/Master- and Reference Data Management Theme 5 Pharmacovigilance Theme 6 Regulatory Science Theme 7 Medical Devices and Combination Products Theme 8 HTA, Value and Access Theme 9 Information on Medicines, Medical Writing and Dossier Generation Theme 10 Special Populations Exhibiting Opportunities at the EuroMeeting. We invite you to take your brand, product or message to the next level by joining an elite group of professionals who have one goal in mind: to help you reach your full potential. 2,500+ individual

Back to the top

April 2017

ISPE 2017 Europe Annual Conference

April 3-6, 2017

Crowne Plaza Barcelona - Fira Center, Avenida Rius i Taulet 1-3, 08004, Barcelona, Non-U.S., Spain

This year the ISPE 2017 Europe Annual Conference will focus on 'Pharma Manufacturing 2025' and the way to achieve a modern, agile, and flexible production landscape. Prominent questions will be explored and discussed during the conference. What will the main regulatory trends be by 2025? How will the current technology platforms evolve? What will the required skillsets and capabilities of the future workforce be? What does the facility of the future look like and how will operations be managed? How can we guarantee safe supply: no counterfeits, no drug shortages? We will take a closer look at how the following industry trends will impact the pharmaceutical industry: . Change from small to large molecules – is Bio an over-emphasised trend? . Complete revision of Annex 1 – a global template? . Global harmonisation of regulation – or more barriers? . Industry 4.0 and complete digitalised operations and full automation – is our current product design fit for being manufactured automatically? Conference Highlights 3 April Executive Forum – The management perspective on future challenges in pharmaceutical operations 4–5 April Keynotes on Manufacturing, Aseptics, and Quality Four Tracks: Factories of the Future | Advanced Aseptic Processing | Clinical and ATMP Supply Chain | Data Integrity and GAMP | 6 April Plant Tours in the Barcelona area: Grifols, Almirall, and the Biomedical Research Park For exhibition opportunities don't delay and contact us, space is selling quickly!


April 3-6, 2017

McCormick Place, Chicago, IL, United States

Automate showcases the full spectrum of automation technologies and solutions. From traditional industrial applications to cutting edge new technologies, you'll find ways to automate every process in your company.

Bioprocessing and Manufacturing Conference 2017

April 10-12, 2017

The Grand Hyatt, Washington, DC, United States

With new vaccine formulations and technology platforms, vaccine developers need to have the right processes in place to manufacture them during clinical trials and at commercial scale. Use this opportunity to meet with the manufacture and bioprocessing leads who need services for all of the latest manufacturing challenges, from formulating and manufacturing adjuvants, mRNA platforms, VLPs and viral vectors, to technology transfer and continuous manufacturing. Bioprocessing and Manufacturing Conference 2017 is one of the 7 different conference streams at the 17th annual World Vaccine Congress Washington. By bringing seven events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture. Take just three days out of the office to meet over 600+ potential customers who need to find solutions to their challenges. For more information and to register, please visit

Influenza and Respiratory Vaccine Conference

April 10-12, 2017

The Grand Hyatt, 1000 H Street NW, 20001, Washington, DC, United States

This event will tackle the latest issues affecting vaccines for respiratory diseases including influenza, TB, RSV and MERS to stimulate the industry to develop more effective vaccines. Ensure you use this event to make people aware of your expertise around key topics such as universal and seasonal flu, maternal immunization and pandemic preparedness. Influenza and Respiratory Vaccine Conference is one of the 7 different conference streams at the 17th annual World Vaccine Congress Washington. By bringing seven events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture. Take just three days out of the office to meet over 600+ potential customers who need to find solutions to their challenges. For more information and to register, please visit

The International Liver Congress 2017

April 19-23, 2017

RAI Amsterdam, Amsterdam, Non-U.S., Netherlands

Anyone interested in hepatology, gastroenterology, internal medicine, cell biology, transplant surgery, infectious diseases, microbiology and virology, pharmacology, pathology and radiology and imaging should attend. Specialists share recent data, present studies, and findings, and discuss the hottest topics on liver disease. The annual Congress attracts in excess of 10,000 delegates and 250 media representatives from all over the world making this a truly international networking opportunity!

US GCP Fundamentals for Pharmaceutical and Biologic Companies

April 20-21, 2017

venue to be announced shortly, San Francisco, CA, United States

Good Clinical Practice (GCP) is a term used to describe a collection of various FDA regulations that govern the conduct of clinical trials. It includes regulations which apply to Sponsors and Contract Research Organizations (CROs) who run the trials, the clinical trial sites and Investigators who conduct the research, the Institutional Review Boards ("IRBs" or Ethics Committees) who oversee the conduct of the trials, and includes other aspects such as avoidance of financial conflict of interest on the part of clinical investigators. The FDA conducts inspections at all of these levels to determine if there has been compliance with GCP, and if not, the agency may take any of a variety of enforcement actions

eyeforpharma Philadelphia 2017

April 20-21, 2017

Sheraton Philadelphia Society Hill Hotel, Philadelphia, PA, United States

It’s eyeforpharma Philadelphia’s 15th year; already the largest, most senior and most influential forum for commercial pharma executives, but now in line for a reboot as we aim to position our industry ahead of the curve. Victory requires far more than just SFE, MCM and KAM – it means becoming the health partner of choice. We, as patients, are becoming consumers. We’re looking for value. We expect quality and real-time delivery. We are more than just empowered – we’re in charge. This is your opportunity to join the discussion with 2 days of expert presentation, interactive panels, keynote presentations and exclusive networking. Join the most forward thinking speaker from across North America including C-level, VPs and industry leaders from Shire, Otsuka, GSK, Novartis, Pfizer, Google, Sanofi, Takeda and many more. This is the ideal place to ensure your commercial strategy is prepared for 2017 and beyond. Full meeting details here

10th Annual Proteins and Antibodies Congress

April 24-25, 2017

Novotel London West, London, Non-U.S., United Kingdom

Oxford Global is proud to present our 10th Annual Proteins and Antibodies Congress. In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 50 speakers will present a full conference programme covering the topics outlined below. These topics have been compiled as a result of a comprehensive research process undertaken with an expert advisory board with members including Executive Directors and Professors from global pharmaceutical organisations and leading research institutions. Delegates will also have the opportunity to attend our co-located inaugural Biotherapeutics Congress. The congress will cover 5 interactive streams: Advances in Protein Engineering, Design & Selection; Updates in antibody structure and dynamics; Cloning, Expression, Purification & Analytics; Antibody Biotherapeutics and Protein Biotherapeutics.

4th Annual Peptides Congress 2017

April 24-25, 2017

To be confirmed, London, Non-U.S., United Kingdom

Oxford Global Conferences are proud to announce the 4th Annual Peptides Congress, taking place on 24 – 25 April 2017 in London, UK. This highly anticipated conference provides a unique opportunity for over 400 senior-level delegates to engage in scientific discussions about the current research results and latest advancements that help the industry going forward.Over 25 presentations and case studies focusing on the key advancements in peptides technologies, chemistry, formulation & delivery as well as peptide therapeutics Two-day interactive conference addressing three main themes: - Recent Progress in Peptide Technologies & Manufacturing - Peptide Discovery & Development: Peptide Chemistry, Formulation & Delivery - Advances in Peptide Therapeutics Co-located with the 10th Annual Proteins & Antibodies Congress, the event will have 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities The 2017 Peptides Congress features a revamped conference agenda that will focus on peptide technologies & manufacturing as well as peptide chemistry, formulation & delivery on Day 1. Stream 1 will feature presentations covering recent progress in peptide synthesis, advancements in peptide screening as well as updates in peptide stabilisation and efficient manufacturing of peptides. In Stream 2 our highly acknowledged speakers will focus on such hot topic areas as utilising macrocyclic peptides in drug discovery, novel strategies for peptide formulation and devices for the effective delivery of peptides. The areas of enhancing the immunogenicity of peptides as well as peptide analysis & quantification will also be addressed. Day 2 of the event will focus on peptide therapeutics. Novel case studies from exciting research areas such as diabetes, metabolic diseases and well as abdominal pain disorders will be covered. Renowned experts will also deliver talks on peptide drug conjugates, peptide-based vaccines and immunotherapies.

6th Digital Marketing for Medical Devices West

April 24-26, 2017

Argonaut Hotel, 495 Jefferson Street, 94109, San Francisco, CA, United States

Digital Marketing for Medical Devices West is designed to provide device marketers with the tools they need to improve brand recognition, increase sales and ensure their products are front-of-mind for their customers, whether they are surgeons, patients and/or hospital administrators. As part of the longest-running and best-attended event series specifically for device marketers, the 6th Digital Marketing for Medical Devices West conference is a must-attend event for anyone looking to learn from industry leaders and network with peers.

Precision Medicine Congress

April 25-26, 2017

To be confirmed, London, Non-U.S., United Kingdom

Oxford Global is proud to present its Inaugural Precision Medicine Congress, on the 25th & 26th of April 2017 in London. Over two days our event will bring together 300 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of precision medicine. This event provides an ideal platform to participate in formal 1-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field. The conference programme will consist of 2 interactive streams covering: - Precision Medicine and Diagnostics in Discovery and Clinical Development - Precision Medicine and Genomics Across the two-day event, our expert panel will offer a comprehensive look at critical advances in diagnostic and genomic research. We will also be hosting key biotech solution providers, giving attendees the chance to hear about the very latest state-of-the-art technologies including NGS and rapid Biomarker analysis platforms. The meeting will cover the discovery of diagnostic developments in therapeutic areas. And how to understand the current issues in precision medicine and genomics. The event will be co-located with our Inaugural Advances in Companion Diagnostics Congress. For more information on how to register for the meeting please contact

Advances in Companion Diagnostics Congress

April 25-26, 2017

TBC, London, Non-U.S., United Kingdom

Oxford Global Conferences are proud to present the Inaugural Advances in Companion Diagnostics Congress, taking place on the 25-26 April 2017 in London. Over two days our event will bring together 300 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of companion diagnostics. This event provides an ideal platform to participate in formal 1-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field. Companion diagnostics are laboratory tests and test kits used to determine the suitability of patients for tailored or targeted forms of therapy, e.g., therapies that act on unique biochemical pathways or that require specific genotypes or mutations. Diagnostics are used to assist in the identification of genetic mutations with implications regarding health and treatment decisions. Genetic testing has become an important piece of the continuously evolving health-care model. It is now possible to identify diseases before symptoms appear, predict the likelihood of disease development, and implement lifestyle or therapeutic interventions that will reduce or eliminate the effects of disease. Closer investigation into the nature of disease has sometimes revealed a more complex set of interactions than what was previously understood. While human DNA has similarities, there are also many individual differences. On day one our esteemed speakers will discuss the progress of diagnostic development in therapeutic areas. There will be a whole stream dedicated to exploring the opportunities and challenges of diagnostic development, including the regulatory issues surround the tests, and a number of clinical case studies with a focus on biomarkers, exosome markers and glycol-biology. Day one will also focus on the current issues surrounding imaging, with a wide range of talks focussing on different imaging technologies such as digital PCR and personalised molecular imaging. On day two the event will move more toward the advances in molecular diagnostics, with an analysis of how MDx is being applied to key areas such as auto-immune disease and oncology. We will also hear from experts discussing the use the liquid biopsy and the quest to make it more efficient. You will have the opportunity to hear from key figures as to how CDx is being used in new and exciting therapeutic areas such as primary care, rare disease and neuroscience. The conference will also focus on how CDx is being used in collaboration with NGS technologies. For more information please contact Danielle:

Back to the top

May 2017

Orphan Drugs and Rare Diseases Europe 2017

May 15-16, 2017

Crowne Plaza, Potsdamer, Platz, Berlin, Non-U.S., Germany

SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market. Germany is Europe's largest pharma market but is recognised as having one of the toughest pricing policies in Europe. Smi 6th annual Orphan Drugs conference will discuss the controversial German pricing mechanism as well as bring together leading industry professionals to discuss the latest regulatory developments, explore how to reduce costs and learn from the latest innovations in the orphan drug landscape.

Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation): 2-Day Workshop

May 15-16, 2017

Venue to be announced shortly, Boston, MA, United States

Course Description: The Process Validation Guidelines (January 2011) and the EU Annex 15: Qualification and Validation (October 2015) outline the general principles and approaches the two regulatory bodies consider appropriate elements of process validation for the manufacture of human and animal drugs and biological products, including Active Pharmaceutical Ingredients (APIs). 
This two day, interactive Seminar which provides a conduit to enhance your understanding of the Continued Process Verification, will be reviewed in detail: where does it begin; what is included; and, when does it end. Common questions asked by the users of Process Validation include; How does one integrate these two different concepts (Phase 1, 2, and 3 vs. Stages 1, 2, and 3) and where do they merge? Do they exist independently of each other or do they complement each other to enhance, build and provide a product that neither alone could. Questions that may arise include where are cGMPs initiated? To what extent must they be used? Since Stage 3 extends through commercial batch manufacturing, what happens to Phase 3? Does it follow along or with Stage 3? Questions that exist include how one manages special situations to include viral inactivation and removal, impurity clearance, process consistency, process solution stability, endotoxin, bioburden, and other miscellaneous cell culture tests to include DNA and host cell protein. These questions will be addressed within Stage 2 as presented here and include utilization of Process Validation and Phase 1, 2 and 3, where their Guidances blend and where they remain distinct. In particular, Stage 3. Important: Please plan to bring a multidisciplinary group from your Company to gain the most from this very important seminar.

2nd Annual Advances in Immuno-Oncology Congress

May 15-16, 2017

Copthorne Tara Hotel, London, Non-U.S., United Kingdom

Oxford Global are proud to present the 2nd Annual Advances in Immuno-Oncology Congress, taking place 15-16 May 2017 in London UK. The event features 200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies. 36 presentations and case studies will focus on the key developments in Immuno-Oncology with specific reference to the discovery of therapeutic areas, pre-clinical and clinical studies, screening, assays and modelling. The congress has 4 interactive streams: • Discovery of Immuno-Oncology Therapies • Pre-clinical Immuno-Oncology • Screening, Assays and Modelling in Immuno-Oncology • Immuno-Oncology: Therapeutic Approaches, Clinical Research and Clinical Trials 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.

Orphan Drugs and Rare Diseases Europe 2017

May 15-16, 2017

Berlin, Non-U.S., Germany

SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market.

Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC)

May 16-17, 2017

Venue to be announced shortly, Philadelphia, PA, United States

This interactive one-and-a-half-day seminar is intended to educate regulatory and quality professionals regarding the rather complicated regulations that distinguish Non-prescription Drugs from other products such as foods, cosmetics, dietary supplements and prescription drugs that sometimes contain the same ingredients. Recent FDA actions such as the banning of antibacterial soaps and ongoing programs that may impact manufacturers and private label distributors will be discussed. It will explain differences in the way homeopathic and conventional drugs are regulated and update participants on FDA’s application of GMP regulations to manufacturing low risk drugs that could be sold as cosmetics with the same ingredients, but different labeling.

CPhI North America

May 16-18, 2017

Pennsylvania Convention Center , Philadelphia, PA, United States

CPhI North America will be the epicenter of pharmaceutical innovation, emerging trends, insights, and community-building connections in North America. It will bring together those seeking powerful partnerships to illuminate the path towards high growth in this ever-evolving industry. The inaugural event will take place on May 16–18, 2017, at the Pennsylvania Convention Center in Philadelphia, PA, adjacent to InformEx, the home of fine and specialty chemicals. Pharmaceutical executives along with R&D, compliance, regulatory, manufacturing, QA/QC, supply chain, packaging, and procurement professionals will gather to build connections to capitalize on emerging trends, further innovation, and tackle industry challenges. The launch of CPhI North America has been strategically timed to take advantage of strong industry growth and innovation while addressing the ever-increasing challenges to the future prosperity of the industry. CPhI North America has been expressly designed to serve the full pharmaceutical value chain. The exhibit floor will be zoned to facilitate a more intimate and efficient experience allowing attendees to customize their experiences. -iCSE: The Drug Development zone will highlight world-class CROs and other organizations serving drug developers. -CPhI North America: The Manufacturing Ingredients zone will consist of active product ingredients (API) and excipient leaders. -FDF: The Finished Drug Products zone will feature leading small and large molecule CDMO/CMOs. -InnoPack: The Packaging zone will showcase packaging innovation. In addition to the zoned exhibit floor populated with leading industry organizations and solutions, CPhI North America will include the following opportunities: -Innovation Zones: These zones will presenting cutting-edge technology, products, and approaches. The zones will allow industry professionals to gather to network and discuss innovations and challenges of common interest and mutual benefit. -Networking Sessions: These events will bring the industry at large together, and smaller targeted events will be held for specific functions or specific areas of interest. -One-on-One Matchmaking: This opportunity will facilitate connections that accomplish individual and organizational objectives. -World-class Educational Programming: CPhI North America has forged strategic partnerships with the American Chemical Society (ACS), the largest scientific association in the world, and CBI, the industry leader in actionable life sciences content and analysis. Through these partnerships, CPhI North America has created rich programming that addresses the full spectrum of the pharmaceutical value chain. The educational programming will include 24 Master Classes covering the most pressing topics within drug development, formulation, manufacturing, and outsourcing. In addition, the programming will include Regulatory Town Hall and keynote sessions with the FDA and leading global regulators.


May 16-18, 2017

Pennsylvania Convention Center, Philadelphia, PA, United States

At InformEx, leading-edge global innovation meets a dynamic community of industry leaders within the evolving fine, specialty, and custom chemicals industry. On May 16–18, 2017, a better-than-ever InformEx will be held at the Philadelphia Convention Center adjacent to CPhI North America’s debut. 340+ InformEx exhibitors and 2,500+ attendees from 30 countries will gather at this hub of fine and specialty chemical innovation. The specialty chemicals industry is changing in very meaningful ways. Chemical product innovation is now often more incremental progress rather than the blockbuster advancements of the 20th century, emerging markets are driving much of the industry’s growth, volatility in numerous end-use markets is difficult to manage, and increasing regulatory demands are creating further complexity. On the other hand, high-performance technologies, value-adding digital technologies and the demand for environmentally friendly products present tremendous opportunities. These industry-driving changes within the fine and specialty chemicals industry created the need to evolve InformEx’s 32-year legacy to meet new market demands. An Evolving Event for a Changing Industry InformEx 2017 has evolved in critical ways while drawing on the decades of experience the organization has serving the fine and specialty chemicals market. This evolution has led to dynamic conference programming, the Innovation Highway, a move to Philadelphia, and adjacency to CPhI North America. The 2017 Conference Program will foster dialogue on innovation and commercialization trends, regulatory challenges, market dynamics, and opportunities for growth within today’s rapidly growing chemical markets, including the broader energy field, personal care, life sciences, and agrochemicals. Educational sessions will highlight opportunities in new innovative sub-segments, such as green chemistry, 3-D printing, and electronic chemicals. The American Chemical Society (ACS), the largest scientific organization in the world, and The Society of Chemical Manufacturers and Affiliates (SOCMA) are serving as strategic partners to help build an outstanding 2017 conference program. InformEx 2017 will feature the Innovation Highway, which will connect InformEx and CPhI. The Innovation Highway will feature opportunities for collaboration and innovation between the specialty chemical and pharmaceutical industries.

World Advanced Therapies and Regenerative Medicine Congress

May 17-19, 2017

Business Design Centre, London, 52 Upper Street, Islington, London, Non-U.S., United Kingdom

In May 2017 the newly named World Advanced Therapies and Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs (Advanced Therapy Medicinal Products). From clinical translation to commercialisation this congress will bring you the most exciting case studies and new data for stem cells, gene therapy, TCRs and gene editing. Experts in every area will help you tackle the process and regulatory hurdles of developing all new therapeutic formats all the way through manufacture and into the clinic. The event will take place alongside the co-located World Precision Medicine Congress and Cord Blood World Europe, hosting 200+ speakers, 7 tracks of content across the 3 days, enabling networking opportunities with 800+ leading industry professionals. Key topics include: . The next generation of ATMPs . Regulation, reimbursement and commercialisation for advanced therapies around the globe . CRISPR and gene editing . Stem cells as a tool for drug discovery . What's next for cell and gene therapy, new era of regenerative medicine? . New paradigms in manufacture: gene therapy and viral vectors . Clinical development of immunotherapy and cell therapy . New frontiers in repair and replacement of diseased tissues and organs . Product, process and manufacturing development of ATMPS

Highly Potent Active Pharmaceutical Ingredients (HPAPI) 2017

May 22-23, 2017

Copthorne Tara Hotel, Scarsdale Place, Kensington, London, Non-U.S., United Kingdom

The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. The inaugural Highly Potent Active Pharmaceutical Ingredients conference features key speakers of the industry presenting challenges, issues, innovation and new developments in various areas of HPAPI production, development and manufacturing. Hear about new innovative containment risk assessment tools and containment strategies when handling HPAPI products. Guidance for the evaluation and management of cross-contamination will be addressed, as well as newest control strategies and solutions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions.

Highly Potent Active Pharmaceutical Ingredients (HPAPIs)

May 22-23, 2017

Capthone Tara Hotel , London , Non-U.S., United Kingdom

The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions

euroPLX 64 Vienna Pharma Partnering

May 29-30, 2017

Austria Trend Hotel Savoyen, Vienna, Non-U.S., Austria

Vienna calling! Pharma Business Development Insiders choose Vienna as one of the best summer venues for the 64th euroPLX Partnering Conference. Seeking and offering business opportunities is what the 64th euroPLX international pharma partnering conference is all about. Once again it will be attended by pharma business development key players. It is the preferred business platform for business development decision makers of more than 1,500 pharma and biotech companies from 81 countries worldwide since more than 21 years: CEOs, owners, vice presidents, directors, and BDandL managers of drug developing, producing, or marketing and distribution companies. For sponsorship opportunities please download the Sponsorship Opportunites Flyer (PDF) from the euroPLX 64 Vienna page or contact us.

Back to the top

June 2017

18th Annual Drug Discovery Summit

June 12-13, 2017

Hotel Palace Berlin, Berlin, Non-U.S., Germany

This summit brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions. Our co-located 5th Discovery Chemistry & Drug Design Congress provides an unprecedented opportunity to gain insights from key presenters of the computational chemistry, discovery chemistry and medicinal field.

13th European Congress of Clinical Pharmacology and Therapeutics - EACPT 2017

June 24-27, 2017

CLARION CONGRESS HOTEL PRAGUE, Freyova 33 - 190 00, Prague, Non-U.S., Czech Republic

The main focus of EACPT 2017 is the role of clinical pharmacology in personalized pharmacotherapy, both a priori – pharmacogenetics – and a posteriori (therapeutic drug monitoring). The topic list includes a broad spectrum of topics that relate to Clinical Pharmacology: - Access to medicines. Innovation and sustainability of National Health Systems - Cardiovascular pharmacology and diabetes - Clinical toxicology - Clinical trials methodology - Drug development and regulatory sciences - Drug Safety and pharmacovigilance - Education - Global Health - Research Ethics - Pharmacoeconomics and health technology assessments - Inflammatory and immune based diseases and treatments - Infectious diseases. Antibiotics, antivirals, antifungals. - Neuro-psychopharmacology - Oncology - Orphan medicines - Research using Electronic Health Records. - Pharmacology of pain - Pharmacogenetics and pharmacogenomics - Pharmacokinetics, TDM, PK-PD modelling and drug interactions - Special populations

DCAT Sharp Sourcing 2017

June 27-27, 2017

Hyatt Regency Hotel, New Brunswick, NJ, United States

DCAT Sharp Sourcing 2017 is a conference and networking event that provides peer and customer insight on the best practices and practical ways for optimizing pharmaceutical manufacturing and supply networks. The event is designed for senior to mid-level executives engaged in sourcing, procurement, supply management, and external manufacturing and their business counterparts on the supply side. It is organized by the Drug, Chemical & Associated Technologies Association (DCAT).

World Conference on Pharmaceutics and Drug Delivery Systems

June 29 - July 1, 2017

Melia Valencia , Valencia , Non-U.S., Spain

Recommended: Pharma Conferences |Pharmaceutical Conferences | Pharmacy Conferences Magnus Group invites all the participants to World Conference on Pharmaceutics and Drug Delivery Systems (PDDS 2017) which is going to be held during June 29- July 01, 2017 at Valencia, Spain. The (PDDS 2017) World Conference on Pharmaceutics and Drug Delivery Systems will bring together a collection of investigators who are at the forefront of their field, and will provide opportunities for junior scientists and graduate students to interactively present their work and exchange ideas with established senior scientists. At Congress, you’ll learn the latest developments in Drug Delivery Systems in sessions led by renowned scientists across the globe. Plus, you’ll have the opportunity to connect with more than 500 of your peers and celebrate your profession. You’ll leave better educated and more invigorated than you thought possible. We wish to see you in Valencia, Spain. Recommended: Pharma Conferences |Pharmaceutical Conferences | Pharmacy Conferences

Back to the top

September 2017

5th International Conference on Current Trends in Mass Spectrometry

September 25-27, 2017

Hilton Atlanta Airport, 1031 Virginia Ave, Atlanta, GA, United States

Mass Spectrometry 2017 is a unique opportunity to discuss best practices within the laboratory research and those in other industries if the people are doing related things getting a variety of viewpoints can help us see where we can change or improve our own ideas and processes. Mass Spectrometry 2017 conference designed in all aspects of application including electrospray ionization and mass spectrometry imaging. There will be many seminars, workshops and technical sessions take place which will catch the attention of the professionals to attend Mass Spectrometry conference and it would enormously enrich our knowledge in understanding the current requirements of the global pharmaceutical industry and LCMS/GCMS.

Back to the top

November 2017

BioData World Congress

November 1-3, 2017

Wellcome Genome Campus, Wellcome Genome Campus Hinxton, CB10 1RQ, Cambridge, Non-U.S., United Kingdom

Held with the support of the Sanger Institute, the EBI the Global Alliance for Genomics and Health and The Pistoia Alliance, BioData World Congress aims to showcase innovation, demonstrate success and break through the obstacles and barriers to ensure that the innovations in genomics get to the patient with speed and efficiency. With a mixture of keynote sessions, roundtables, focused work tracks, site visits, product demonstrations and networking parties, this event will push the boundaries in order to realise the power of big data in precision medicine.

South African Pharmaceutical Exhibition (SAPHEX)

November 28-29, 2017

Sandton Convention Centre, 161 Maude Street, Sandton, Non-U.S., South Africa

Saphex is rapidly establishing itself as the most strategic industry event in the South African region that brings together all major stakeholders – industry leaders, policy-makers, regulators, academics, investors, scientists and patient representatives, to tackle the most pressing issues the industry is facing. With over 2000 visitors expected at Saphex 2017, there will be ample opportunity for you to connect and establish relationships with fellow professionals from the pharmaceutical industry. We are also anticipating over 130 exhibitors and over 100 countries represented at the event. The event will incorporate an exhibition and a conference, delivering business contacts and forging strategic alliances in combination with the knowledge and information that you will need to win in the South African pharmaceutical sector. Saphex will be held under the theme, 'Continuing development of the South African Pharmaceutical Industry: Forging ideas for the future composition of the sector'. Aiming to explore the current composition of the industry in South Africa, and inviting several experts in their respective fields to give their opinion on where the future of the market may lead. The approach that companies pursue will hinge upon their individual goals. Inevitably companies will need to decide how to satisfy contending stakeholder demands while pursuing sustainable growth in a competitive market.

Back to the top